Encompass Health Corporation Receivables, Net, Current
Encompass Health Corporation (EHC) had Receivables, Net, Current of $687.30 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2026-08-07
- 2026-06-30: Receivables, Net, Current $687.30M.
- 2026-03-31: Receivables, Net, Current $676.00M.
- 2025-12-31: Receivables, Net, Current $619.20M.
- 2025-09-30: Receivables, Net, Current $610.80M.
| Period end | Receivables, Net, Current | Receivables, Net, Current as first filed |
|---|---|---|
| 2026-06-30 | $687.30M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $676.00M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $619.20M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $610.80M 10-Q · filed 2025-10-31 | |
| 2025-06-30 | $612.50M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $623.40M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $598.80M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $576.40M 10-Q · filed 2024-11-01 | |
| 2024-06-30 | $589.70M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $619.30M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $611.60M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $535.90M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $532.30M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $514.50M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $536.80M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $515.80M 10-K · filed 2023-02-27 | $680.30M 10-K · filed 2022-02-25 |
| 2020-12-31 | $572.80M 10-K · filed 2022-02-25 | |
| 2019-12-31 | $506.10M 10-K · filed 2021-02-26 | |
| 2018-12-31 | $467.70M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $472.10M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $443.80M 10-K · filed 2018-02-28 | |
| 2015-12-31 | $410.50M 8-K · filed 2017-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |